Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2a,Condition 2b,Condition 2c 2561,"Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000.",erythrocyte quantity,,RS:0000592,MW,male,0 days,8,,CMO:0000037,hematocrit,,,,36,%,1.0,2.8284,MMO:0000214,hematocrit analysis,,0.0,,5/6 nephrectomy,28,days,nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and hydrochlorothiazide (25 mg/l) (for 21 days),100988,nephrectomy (for 28 days),reserpine (5 mg/l) (for 21 days),hydralazine (80 mg/l) (for 21 days),hydrochlorothiazide (25 mg/l) (for 21 days) 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",erythrocyte quantity,,RS:0000592,MW,male,0 days,10,,CMO:0000037,hematocrit,,,,48.4,%,1.4,4.4272,MMO:0000214,hematocrit analysis,,0.0,,~5/6 to 7/8 nephrectomy,56,days,right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and hydrochlorothiazide (25 mg/l) ,100849,right nephrectomy (for 56 days),reserpine (5 mg/l) ,hydralazine (80 mg/l) ,hydrochlorothiazide (25 mg/l) 2523,"Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55.",erythrocyte quantity,,RS:0000592,MW,male,0 days,10,,CMO:0000037,hematocrit,,,,45.8,%,0.7,2.2136,MMO:0000214,hematocrit analysis,,0.0,,~5/6 to 7/8 nephrectomy,112,days,right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and hydrochlorothiazide (25 mg/l) (for 56 days),100856,right nephrectomy (for 112 days),reserpine (5 mg/l) (for 56 days),hydralazine (80 mg/l) (for 56 days),hydrochlorothiazide (25 mg/l) (for 56 days)